Recent clinical studies corroborate these findings, reporting significantly elevated serum levels of IL-1β and IL-18 in SLE patients—highlighting the clinical relevance of inflammasome-derived cytokines in disease progression (214, 215). The gene discussed is IL18; the disease is systemic lupus erythematosus.